StayCurrentMD · Congenital Diaphragmatic Hernia: APSA Prenatal Counseling Series
Guideline10 min read·Published Nov 2019Older

Congenital Diaphragmatic Hernia: APSA Prenatal Counseling Series

Guideline · Nov 2019 · 10 min read

In brief

In brief

APSA's prenatal counseling guidance for congenital diaphragmatic hernia provides evidence-based information for expectant parents and clinicians. Covers diagnosis, prognosis, treatment options, and postnatal management strategies for this complex congenital anomaly.

  • CDH prognosis depends on liver herniation, pulmonary hypoplasia severity, pulmonary hypertension, and associated cardiac/genetic anomalies
  • Sac-type CDH has residual diaphragm membrane and carries improved prognosis compared to complete diaphragmatic absence
  • Differential diagnosis includes Morgagni/hiatal hernias, CPAM, BPS, and pulmonary agenesis/hypoplasia—imaging distinguishes these
  • Prenatal counseling requires multidisciplinary assessment of herniation degree and associated anomalies to guide delivery planning

Written by the GCMD Library team from the guideline.

Definition and Pathophysiology of CDH

Congenital diaphragmatic hernia involves absence of at least one diaphragm, allowing abdominal organs to herniate into the fetal chest. Morbidity and mortality depend on associated cardiac anomalies, genetic conditions, degree of liver herniation, and severity of pulmonary hypoplasia and hypertension. Sac-type CDH variants with residual diaphragm membrane carry improved prognosis.

Differential Diagnosis

CDH must be distinguished from Morgagni hernia, hiatal hernia, pulmonary agenesis/aplasia/hypoplasia, and thoracic masses including CPAM, bronchopulmonary sequestration, mediastinal lymphatic malformation, and pleuropulmonary blastoma. Accurate prenatal differentiation guides appropriate counseling and management planning.

Obstetrical Ultrasound Assessment

Ultrasound evaluates fetal growth, amniotic fluid volume, anatomic anomalies, and hydrops. Lung-to-head ratio (LHR) and observed-to-expected LHR classify severity: mild (O/E LHR >35%), moderate (25-35%), or severe (<25%). Right-sided CDH generally carries similar or worse prognosis compared to left-sided defects with equivalent parameters.

Fetal Echocardiography

Cardiac evaluation assesses position, structure, and function, as coexistent congenital heart disease dramatically increases mortality, especially with univentricular anatomy. Modified McGoon Index (MMI) <1 indicates high pulmonary hypertension risk by measuring pulmonary artery diameters relative to aortic diameter.

Fetal MRI Evaluation

MRI at diagnosis (typically 24 weeks) excludes alternative diagnoses and evaluates anatomy; optional 34-week MRI provides accurate lung volume assessment. Total lung volume <20 ml or percent predicted lung volume <15% at 34 weeks indicates poor prognosis and guides delivery planning.

Prenatal Counseling and Delivery Planning

Comprehensive counseling involves maternal-fetal medicine, pediatric surgery, neonatology, cardiology, and radiology after complete fetal evaluation including karyotyping. All CDH cases require delivery at tertiary centers with Level 3 NICU access to pediatric surgery and ECMO, with scheduled term delivery (37-38 weeks) and biweekly monitoring from 30 weeks due to 10% third-trimester fetal demise risk.

Fetoscopic Endoluminal Tracheal Occlusion (FETO)

FETO is offered through select U.S. centers participating in the NAFTNET consortium for severe left-sided CDH (O/E LHR <25%) via the TOTAL trial. This represents the only current fetal intervention option for severe cases.

Postnatal Complications and Outcomes

Postnatal course varies with pulmonary hypoplasia and hypertension severity. Families require counseling on risks including hernia recurrence, death, prolonged ventilation, oxygen dependence, neurologic impairment, GERD, feeding difficulties, hearing loss, and chest wall deformities. ECMO-requiring CDH carries substantially higher complication rates across all domains compared to non-ECMO cases.

Long-term Follow-up Requirements

Multidisciplinary clinic follow-up including pediatric surgery, pulmonology, nutrition, and developmental pediatrics is strongly recommended. Long-term sequelae are common and include respiratory complications (25-75% in ECMO cases), neurologic impairment (up to 50% learning difficulties), GERD (up to 75%), and growth failure requiring gastrostomy (up to 50% in ECMO survivors).

Statements in this guideline

  1. Morbidity and mortality of infants born with CDH is dependent on coexistence of congenital heart disease, other congenital or genetic anomalies, degree of herniation of structures into the fetal chest (in particular the liver), degree of pulmonary hypoplasia, and pulmonary hypertension.

    EstablishedCongenital Diaphragmatic Hernia
  2. Sac-type congenital diaphragmatic hernia is a variant in which there is some residual diaphragm membrane with improved prognosis.

    EstablishedCongenital Diaphragmatic Hernia
  3. Mild pulmonary hypoplasia is defined as LHR >1.4.

    GuidelineObstetrical Ultrasound
  4. Moderate pulmonary hypoplasia is defined as LHR 1-1.4.

    GuidelineObstetrical Ultrasound
  5. Severe pulmonary hypoplasia is defined as LHR <1.

    GuidelineObstetrical Ultrasound
  6. Mild CDH is defined as O/E LHR >35%.

    GuidelineObstetrical Ultrasound
  7. Moderate CDH is defined as O/E LHR 25-35%.

    GuidelineObstetrical Ultrasound
  8. Severe CDH is defined as O/E LHR <25%.

    GuidelineObstetrical Ultrasound
  9. A Modified McGoon Index (MMI) <1 indicates high risk for pulmonary hypertension.

    GuidelineFetal Echocardiogram
  10. The combination of congenital heart disease and CDH drastically increases mortality, particularly if univentricular anatomy.

    EstablishedFetal Echocardiogram
  11. Fetal MRI is typically obtained at 24 weeks or around the time of diagnosis to fully evaluate the anatomy and exclude potential alternative or coexistent diagnosis.

    RecommendationFetal Magnetic Resonance Imaging (MRI)
  12. A TLV < 20 ml at 34 gestational weeks indicates a poor prognosis.

    GuidelineFetal Magnetic Resonance Imaging (MRI)
  13. A PPLV of < 15% indicates a poor prognosis.

    GuidelineFetal Magnetic Resonance Imaging (MRI)
  14. All cases of CDH should be delivered in a tertiary care center near a neonatal intensive care unit (NICU).

    RecommendationManagement of Pregnancy and Delivery Planning
  15. Depending on the degree of pulmonary hypoplasia, delivery with ECMO standby should be considered.

    RecommendationPrenatal Counseling and Postnatal Considerations
  16. Biweekly follow up beginning at 30 weeks' gestation is recommended as there is a 10% risk of intrauterine fetal demise during the third trimester even in cases with no other abnormalities except the CDH.

    RecommendationManagement of Pregnancy and Delivery Planning
  17. All CDH babies should be considered high-risk, regardless of prenatal imaging parameters.

    RecommendationManagement of Pregnancy and Delivery Planning
  18. Cesarean section is only indicated for obstetrical considerations.

    RecommendationManagement of Pregnancy and Delivery Planning
  19. Scheduled delivery when full-term (37-38 weeks) should be considered.

    RecommendationManagement of Pregnancy and Delivery Planning
  20. Delivery should occur close to a Level 3 NICU with access to pediatric surgery and ECMO.

    RecommendationManagement of Pregnancy and Delivery Planning
  21. FETO is offered to severe left-sided CDH (identified as O/E LHR<25%) via participation in the TOTAL trial.

    GuidelineConsideration for Fetoscopic Endoluminal Tracheal Occlusion (FETO)
  22. Death occurs in 20-50% of CDH cases requiring ECMO and 5-20% of non-ECMO CDH cases.

    ResearchComplication rates for CDH requiring ECMO vs not requiring ECMO
  23. Prolonged ventilator dependence (> 1 month) occurs in 25-75% of ECMO CDH cases and up to 10% of non-ECMO CDH cases.

    ResearchComplication rates for CDH requiring ECMO vs not requiring ECMO
  24. Long-term supplemental oxygen need (> 6 months) occurs in 25-75% of ECMO CDH cases and up to 10% of non-ECMO CDH cases.

    ResearchComplication rates for CDH requiring ECMO vs not requiring ECMO
  25. Neurologic impairment with learning difficulties occurs in 50% of ECMO CDH cases and 5-20% of non-ECMO CDH cases.

    ResearchComplication rates for CDH requiring ECMO vs not requiring ECMO
  26. GERD managed with medication occurs in 75% of both ECMO and non-ECMO CDH cases.

    ResearchComplication rates for CDH requiring ECMO vs not requiring ECMO
  27. Failure to thrive resulting in need for gastrostomy placement occurs in up to 50% of ECMO CDH cases and up to 10% of non-ECMO CDH cases.

    ResearchComplication rates for CDH requiring ECMO vs not requiring ECMO
  28. CDH recurrence after repair occurs in 10-50% of ECMO cases and 5-20% of non-ECMO cases.

    ResearchComplication rates for CDH requiring ECMO vs not requiring ECMO
  29. It is strongly recommended that CDH babies follow up in a multidisciplinary clinic including pediatric surgery, pulmonary, nutrition and developmental pediatrics due to the abundance of potential long-term sequelae.

    RecommendationFollow-up and Long-term Issues
Full text

American Pediatric Surgical Association Prenatal Counseling Series Congenital Diaphragmatic Hernia from the Fetal Diagnosis and Treatment Committee of the American Pediatric Surgical Association Editor-in-Chief: Ahmed I. Marwan, MD Special thanks to Loren Berman, MD, and Erin Perrone, MD ©2018, American Pediatric Surgical Association TM

American Pediatric Surgical Association Prenatal Counseling Series Congenital Diaphragmatic Hernia Congenital Diaphragmatic Hernia Congenital Diaphragmatic Hernia (CDH) refers to congenital absence of at least one diaphragm, which results in abnormal displacement of typically abdominal structures into the fetal chest. Morbidity and mortality of infants born with this congenital anomaly is dependent on many factors including possible coexistence of congenital heart disease, other congenital or genetic anomalies, degree of herniation of structures into the fetal chest, in particular the liver, degree of pulmonary hypoplasia and pulmonary hypertension. Sac-type congenital diaphragmatic hernia (CDH) is a variant in which there is some residual diaphragm membrane with improved prognosis. Source: Colorado Fetal Care Center

American Pediatric Surgical Association Prenatal Counseling Series Congenital Diaphragmatic Hernia Differential Diagnosis Differential diagnosis of congenital diaphragmatic hernia includes: Morgagni hernia, congenital hiatal hernia, pulmonary agenesis, pulmonary aplasia, pulmonary hypoplasia, pericardial teratoma, congenital pulmonary airway malformation (CPAM), bronchopulmonary sequestration (BPS), mediastinal lymphatic malformation, pericardial teratoma, bronchogenic cyst, neurenteric cyst and pleuropulmonary blastoma. Congenital Diaphragmatic Hernia Congenital Diaphragmatic Hernia (CDH) refers to congenital absence of at least one diaphragm, which results in abnormal displacement of typically abdominal structures into the fetal chest. Morbidity and mortality of infants born with this congenital anomaly is dependent on many factors including possible coexistence of congenital heart disease, other congenital or genetic anomalies, degree of herniation of structures into the fetal chest, in particular the liver, degree of pulmonary hypoplasia and pulmonary hypertension. Sac-type congenital diaphragmatic hernia (CDH) is a variant in which there is some residual diaphragm membrane with improved prognosis. Differential Diagnosis Differential diagnosis of congenital diaphragmatic hernia includes: Morgagni hernia, congenital hiatal hernia, pulmonary agenesis, pulmonary aplasia, pulmonary hypoplasia, pericardial teratoma, congenital pulmonary airway malformation (CPAM), bronchopulmonary sequestration (BPS), mediastinal lymphatic malformation, pericardial teratoma, bronchogenic cyst, neurenteric cyst and pleuropulmonary blastoma. Bochdalek hernia Sac-type hernia Morgagni hernia Hiatal hernia Congenital Diaphragmatic Hernia Congenital Diaphragmatic Hernia (CDH) refers to congenital absence of at least one diaphragm, which results in abnormal displacement of typically abdominal structures into the fetal chest. Morbidity and mortality of infants born with this congenital anomaly is dependent on many factors including possible coexistence of congenital heart disease, other congenital or genetic anomalies, degree of herniation of structures into the fetal chest, in particular the liver, degree of pulmonary hypoplasia and pulmonary hypertension. Sac-type congenital diaphragmatic hernia (CDH) is a variant in which there is some residual diaphragm membrane with improved prognosis. Differential Diagnosis Differential diagnosis of congenital diaphragmatic hernia includes: Morgagni hernia, congenital hiatal hernia, pulmonary agenesis, pulmonary aplasia, pulmonary hypoplasia, pericardial teratoma, congenital pulmonary airway malformation (CPAM), bronchopulmonary sequestration (BPS), mediastinal lymphatic malformation, pericardial teratoma, bronchogenic cyst, neurenteric cyst and pleuropulmonary blastoma. Bochdalek hernia Sac-type hernia Morgagni hernia Hiatal hernia Congenital Diaphragmatic Hernia Congenital Diaphragmatic Hernia (CDH) refers to congenital absence of at least one diaphragm, which results in abnormal displacement of typically abdominal structures into the fetal chest. Morbidity and mortality of infants born with this congenital anomaly is dependent on many factors including possible coexistence of congenital heart disease, other congenital or genetic anomalies, degree of herniation of structures into the fetal chest, in particular the liver, degree of pulmonary hypoplasia and pulmonary hypertension. Sac-type congenital diaphragmatic hernia (CDH) is a variant in which there is some residual diaphragm membrane with improved prognosis. Differential Diagnosis Differential diagnosis of congenital diaphragmatic hernia includes: Morgagni hernia, congenital hiatal hernia, pulmonary agenesis, pulmonary aplasia, pulmonary hypoplasia, pericardial teratoma, congenital pulmonary airway malformation (CPAM), bronchopulmonary sequestration (BPS), mediastinal lymphatic malformation, pericardial teratoma, bronchogenic cyst, neurenteric cyst and pleuropulmonary blastoma. Bochdalek hernia Sac-type hernia Morgagni hernia Hiatal hernia Congenital Diaphragmatic Hernia Congenital Diaphragmatic Hernia (CDH) refers to congenital absence of at least one diaphragm, which results in abnormal displacement of typically abdominal structures into the fetal chest. Morbidity and mortality of infants born with this congenital anomaly is dependent on many factors including possible coexistence of congenital heart disease, other congenital or genetic anomalies, degree of herniation of structures into the fetal chest, in particular the liver, degree of pulmonary hypoplasia and pulmonary hypertension. Sac-type congenital diaphragmatic hernia (CDH) is a variant in which there is some residual diaphragm membrane with improved prognosis. Differential Diagnosis Differential diagnosis of congenital diaphragmatic hernia includes: Morgagni hernia, congenital hiatal hernia, pulmonary agenesis, pulmonary aplasia, pulmonary hypoplasia, pericardial teratoma, congenital pulmonary airway malformation (CPAM), bronchopulmonary sequestration (BPS), mediastinal lymphatic malformation, pericardial teratoma, bronchogenic cyst, neurenteric cyst and pleuropulmonary blastoma. Bochdalek hernia Sac-type hernia Morgagni hernia Hiatal hernia Bochdalek hernia Figure 1 Fig.1: Fetal MRI with Single Shot Fast Spin Echo coronal image demonstrating fluid filled stomach and bowel loops in the left chest. Both the left and right lung are displaced superior and to the right and are small in size (arrows). Fig. 2: Fetal MRI with SSFSE parasagittal image demonstrating bowel loops and left lobe of the liver (arrow) in the left thorax. Images courtesy of Kimberly Dannull, MD, Colorado Fetal Care Center Figure 2 Morgagni herniaSac-type hernia Hiatal hernia Representative MRI images of some of the differential diagnosis

American Pediatric Surgical Association Prenatal Counseling Series Congenital Diaphragmatic Hernia Initial Evaluation Obstetrical Ultrasound Fetal echocardiography Fetal magnetic resonance imaging Prenatal Imaging The goal of prenatal imaging is to exclude alternative diagnoses, evaluate for additional congenital anomalies, identify location and contents of the hernia, predict outcome and guide perinatal and postnatal management. Obstetrical Ultrasound • Evaluate fetal growth • Evaluate the amount of amniotic fluid. The herniated stomach can result in polyhydramnios, which can predispose to preterm labor and delivery • Evaluate anatomy for the presence of other potential congenital anomalies • Evaluate for hydrops: pleural fluid, ascites, pericardial fluid, skin edema, placentomegaly • Measure the Lung-to-Head Ratio (LHR) (Length x width of the lung opposite the side of the hernia, divided by the head circumference with formula L x W /HC) o Mild pulmonary hypoplasia: LHR >1.4 o Moderate pulmonary hypoplasia: LHR 1-1.4 o Severe pulmonary hypoplasia: LHR<1 • Observed-to-expected LHR should be calculated o Mild CDH: O/E LHR >35% o Moderate: O/E LHR 25-35% o Severe: O/E LHR <25% • Right- vs left-sided CDH: Most experts feel that right-sided diaphragmatic hernia has a same or worse prognosis compared to left-sided defect with similar parameters, with the exception of liver position (the liver is always up with right-sided defect as it is the only organ immediately beneath the right diaphragm.) o Mild pulmonary hypoplasia: LHR >1.4 o Moderate pulmonary hypoplasia: LHR 1-1.4 o Severe pulmonary hypoplasia: LHR<1 • Observed-to-expected LHR should be calculated (Zaretsky to add detail of this method) o Mild CDH: O/E LHR >35% o Moderate: O/E LHR 25-35% o Severe: O/E LHR <25% • Modified McGoon Index (MMI) is obtained to evaluate risk for pulmonary hypertension: (diameter of the left pulmonary artery plus the right pulmonary artery divided by the aorta at the level of the expected diaphragm (LPA + RPA/Aorta). A MMI <1 indicates high risk for pulmonary hypertension. • Right- vs left-sided CDH: Most experts feel that right-sided diaphragmatic hernia has a same or worse prognosis compared to left-sided defect with similar parameters, with the exception of liver position (the liver is always up with right-sided defect as it is the only organ immediately beneath the right diaphragm.) Fetal Echocardiogram • Evaluate cardiac position, structure and function (the combination of congenital heart disease and CDH drastically increases mortality, particularly if univentricular anatomy) • Modified McGoon Index (MMI) is obtained to evaluate risk for pulmonary hypertension: (diameter of the left pulmonary artery plus the right pulmonary artery divided by the aorta at the level of the expected diaphragm (LPA + RPA/Aorta). A MMI <1 indicates high risk for pulmonary hypertension. • Maternal hyperoxygenation response (? Cards to add detail) Fetal Magnetic Resonance Imaging (MRI) • Fetal MRI is typically obtained at 24 weeks or around the time of diagnosis to fully evaluate the anatomy and exclude potential alternative or coexistent diagnosis. An additional MRI is obtained at 34 weeks gestation, which gives a more accurate assessment of lung volumes and better visualization of the pulmonary arteries to predict the risk for pulmonary hypoplasia and pulmonary hypertension respectively. • Obtain lung volumes utilizing volumetric software: o Calculate Total Lung Volume (TLV). The TLV is the simple summation of the volume of the left and right lung (left lung volume + right lung volume). A TLV < 20 ml at 34 gestational weeks indicates a poor prognosis. o Calculate Percent Predicted Lung Volume (PPLV). The expected lung volume is calculated by subtracting mediastinal volume (MV) from the thoracic volume (TV). PPLV is the total lung

American Pediatric Surgical Association Prenatal Counseling Series Congenital Diaphragmatic Hernia Fetal Echocardiogram • Evaluate cardiac position, structure and function (the combination of congenital heart disease and CDH drastically increases mortality, particularly if univentricular anatomy) • Modified McGoon Index (MMI) may be obtained to evaluate risk for pulmonary hypertension: (diameter of the left pulmonary artery plus the right pulmonary artery divided by the aorta at the level of the expected diaphragm (LPA + RPA/ Aorta). A MMI <1 indicates high risk for pulmonary hypertension. • Perform maternal hyperoxygenation response Fetal Magnetic Resonance Imaging (MRI) • Fetal MRI is typically obtained at 24 weeks or around the time of diagnosis to fully evaluate the anatomy and exclude potential alternative or coexistent diagnosis. Some fetal centers will advocate for an optional 34 weeks gestation MRI, which gives a more accurate assessment of lung volumes and better visualization of the pulmonary arteries to predict the risk for pulmonary hypoplasia and pulmonary hypertension respectively. • Obtain lung volumes utilizing volumetric software: o Calculate T otal Lung Volume (TL V). The TL V is the simple summation of the volume of the left and right lung (left lung volume + right lung volume). A TL V < 20 ml at 34 gestational weeks indicates a poor prognosis. o Calculate Percent Predicted Lung Volume (PPL V). The expected lung volume is calculated by subtracting mediastinal volume (MV) from the thoracic volume (TV). PPL V is the total lung volume divided by the expected lung volume (PPL V= TL V /TV-MV). A PPL V of < 15% indicates a poor prognosis. o Similar to prenatal ultrasound and echocardiogram, a modified McGoon index (MMI) may be quantitated

American Pediatric Surgical Association Prenatal Counseling Series Congenital Diaphragmatic Hernia Prenatal Counseling and Postnatal Considerations • After a comprehensive review of the fetus with obstetrical ultrasound, fetal MRI, fetal echocardiography and amniocentesis for karyotyping, then comprehensive counseling can be performed, typically including MFM, pediatric surgeon, neonatologist, pediatric cardiologist and pediatric radiologist. • All cases of CDH should be delivered in a tertiary care center near a neonatal intensive care unit (NICU) • Depending on the degree of pulmonary hypoplasia, delivery with ECMO standby should be considered Management of Pregnancy and Delivery Planning • Biweekly follow up beginning at 30 weeks’ gestation: there is a 10% risk of intrauterine fetal demise during the third trimester even in cases with no other abnormalities except the CDH. • All CDH babies should be considered high-risk, regardless of prenatal imaging parameters. • Cesarean section is only indicated for obstetrical considerations. • Scheduled delivery when full-term (37-38 weeks) should be considered. Many, but certainly not all, specialists believe scheduled delivery is necessary, but true readiness is important - and few centers truly are ready 24/7 . • Delivery should occur close to a Level 3 NICU with access to pediatric surgery and ECMO. Consideration for Fetoscopic Endoluminal Tracheal Occlusion (FETO) Currently, FETO is offered through a handful of centers within the U.S. who participate in the North American Fetal Therapy Network (NAFTNET) FETO consortium. FETO is offered to severe left-sided CDH (identified as O/E LHR<25%) via participation in the TOTAL trial.

American Pediatric Surgical Association Prenatal Counseling Series Congenital Diaphragmatic Hernia Postnatal Course The postnatal course can be variable depending on the degree of pulmonary hypoplasia and pulmonary hypertension. Risks to discuss with families during prenatal consultation: • The following long-term outcomes should definitely be discussed during prenatal consultation for a fetus with CDH: o Recurrence of hernia o Death o Long-term O2 supplementation o Ventilator dependency o Neurological problems o GERD o Asthma, reactive airway disease o Hearing loss o G tube dependence o Failure to thrive o Chest wall deformities o Intestinal obstruction o Diuretic dependence

American Pediatric Surgical Association Prenatal Counseling Series Congenital Diaphragmatic Hernia Complication rates for CDH requiring ECMO vs not requiring ECMO OUTCOME Rate for ECMO CDH Rate for non-ECMO CDH Prolonged ventilator dependence ( > 1 month) 25-75% Up to 10% Long-term supplemental oxygen need ( > 6 months) 25-75% Up to 10% Asthma or reactive airway disease as a school-aged child 25-75% 10-50% Neurologic impairment: Learning difficulties 50% 5-20% Neurologic impairment: Unable to attend regular school 10-20% 1-5% Long-term hearing loss: Mild loss without need for medical assistance Up to 50% 1-5% Long-term hearing loss: Requiring hearing aid 5-10% 1% Long-term hearing loss: Hearing loss impacting speech development 5-10% 1% GERD: Managed with medication 75% Up to 75% GERD: Managed with fundoplication 20% Up to 10% Failure to thrive resulting in need for gastrostomy placement Up to 50% Up to 10% Intestinal obstruction 5-10% 5-10% Chest wall deformities: Mild 10-20% 10-20% Chest wall deformities: Requiring surgery Up to 10% Up to 5% Scoliosis Up to 20% Up to 20% CDH recurrence after repair 10-50% 5-20% Death 20-50% 5-20% Courtesy of Loren Berman, MD Berman L, Jackson J, Miller K, Kowalski R, Kolm P , Luks F. Expert surgical consensus for prenatal counseling using the Delphi method. J Pediatr Surg. 2017 Nov 28. pii: S0022-3468(17)30805-9. Follow-up and Long-term Issues It is strongly recommended that CDH babies follow up in a multidisciplinary clinic including pediatric surgery, pulmonary, nutrition and developmental pediatrics due to the abundance of potential long-term sequelae as detailed above.

Open in a new tab ↗

Read it at the source ↗

Try
Intelligent Search· scoped to this guideline · not medical adviceSearch the whole library →